The following post from the FDA appeared today about complaints that generic long-acting methylphenidates (brand name-Concerta) may not work equally well.
"In the case of the ADHD drug — certain generic versions of methylphenidate hydrochloride (Concerta, Janssen Pharmaceuticals) — the issue is a possible lack of therapeutic effect, which may be ... Read More
Category: Clinician Articles
28
Feb2013
As an advocate for patient education, I direct my patients to credible sources of information on ADHD and associated disorders. Medscape is a highly reputable site for medical professionals and a great site for patients who wish to read about research and the state-of-the-art medicine.
I was invited to write a ... Read More
February 28, 2013David W. Goodman, MD
06
Jun2012
For those with ADHD as an adult, it doesn’t go away. According to the National Comorbidity Survey Replication study published 2006, of those with adult ADHD, 75% were not diagnosed as children.
In my practice it is not uncommon for patients over age 50 to be newly diagnosed. I provided my ... Read More
June 6, 2012David W. Goodman, MD
05
Nov2009
The prevalence of attention-deficit/hyperactivity disorder (ADHD) in adults 18-44 years of age range from 4.4% to 5.2%. The proportion of those adults who receive pharmacologic or nonpharmacologic treatment for ADHD is only 10.9% to 12.6%, indicating that ADHD remains undiagnosed and untreated in millions of adults in the United States. ... Read More
November 5, 2009David W. Goodman, MD
05
Feb2009
Attention Deficit/Hyperactivity Disorder (ADHD) is a commonly diagnosed psychiatric disorder that leads to significant impairment across the lifespan. Although historically defined as a childhood disorder, the adult manifestation has more recently been identified; yet, many adults with this disorder remain unidentified and untreated. This series of 15 short articles provide ... Read More
February 5, 2009David W. Goodman, MD
05
Feb2009
Based on the National Comorbidity Survey Replication (NCS-R), 18.6% (SE=4.2%) of study participants with ADHD also had MDD, compared with 7.8% (SE=0.4%) who had MDD but did not have ADHD (OR=2.7; 95% CI, 1.5-4.9) (Table 2). All comorbid conditions were significantly greater in the ADHD populations but did not vary ... Read More
February 5, 2009David W. Goodman, MD
05
Feb2009
Recent studies have suggested that late-onset adult ADHD is valid and that the DSM-IV’s age-at-onset criterion of age 7 is too stringent. Given the lack of empirical evidence supporting the age-at-onset criteria of ADHD, combined with practical difficulties in demonstrating impairment before age 7 in older adolescents and adults, some ... Read More
February 5, 2009David W. Goodman, MD
05
Feb2009
The diagnosis of ADHD is best determined by a combination of a comprehensive history, adherence to well-described clinical criteria, and training in the differential diagnosis of adult disorders. Neuropsychiatric testing is beneficial for assessing learning disabilities, executive function, and other cognitive impairments, but it has not demonstrated value in the ... Read More
February 5, 2009David W. Goodman, MD
05
Feb2008
A literature search found five empirical studies or psychological treatment for adults with ADHD, out of 1,419 articles on ADHD in adults. Practice guidelines to date all recommend multimodal intervention, given that a significant number of patients cannot tolerate, do not respond to, or fail to rearch optimal outcomes with ... Read More
February 5, 2008David W. Goodman, MD